GB2162173A - Ergoline derivatives - Google Patents

Ergoline derivatives Download PDF

Info

Publication number
GB2162173A
GB2162173A GB08419150A GB8419150A GB2162173A GB 2162173 A GB2162173 A GB 2162173A GB 08419150 A GB08419150 A GB 08419150A GB 8419150 A GB8419150 A GB 8419150A GB 2162173 A GB2162173 A GB 2162173A
Authority
GB
United Kingdom
Prior art keywords
ergoline
methyl
formyl
hydroxyethyl
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08419150A
Other versions
GB8419150D0 (en
GB2162173B (en
Inventor
Luigi Bernardi
Sergio Mantegani
Aldemio Temperilli
Gabriella Traquandi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Priority to GB08419150A priority Critical patent/GB2162173B/en
Publication of GB8419150D0 publication Critical patent/GB8419150D0/en
Publication of GB2162173A publication Critical patent/GB2162173A/en
Application granted granted Critical
Publication of GB2162173B publication Critical patent/GB2162173B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Ergoline derivatives I <IMAGE> (R1 = H or CH3, R2 = C1 - C4 hydrocarbon, R5 = H or OCH3, either R3 + R4 = O or one of R3 and R4 = formyl, 2-oxoethyl or 3-oxopropyl and the other = H, R3 + R4 NOTEQUAL O if R5 = OCH3) are prepared by oxidising ergoline derivatives II <IMAGE> (R1, R2, R5 as above defined, W = hydroxy, hydroxymethyl, 2-hydroxyethyl or 3-hydroxypropyl, W NOTEQUAL OH if R5 =OCH3) with a triethylamine:sulphur trioxide complex.

Description

SPECIFICATION Ergoline derivatives The invention relates to ergoline derivatives and to a process for their preparation.
The invention provides a process for the preparation of an ergoline derivative having the general for miii,, I
wherein R, represents a hydrogen atom or a methyl group, R2 represents a hydrocarbon group having from 1 to 4 carbon atoms, R5 represents a hydrogen atom or a methoxy group, and either R3 and R4 together represent an oxygen atom or one of R3 and R4 represents a formyl, 2-oxoethyl or 3-oxopropyl group and the other of R3 and R4 represents a hydrogen atom, with the proviso that if R5 represents a methoxy group then R3 and R4 together do not represent an oxygen atom, which process comprises oxidizing with a triethylamine: sulphur troxide complex an ergoline derivative having the general formula II
wherein R1, R2 and R5 are as above defined and W represents a hydroxy, hydroxymethyl 2-hydroxyethyl or 3-hydroxypropyl group with the proviso that if R5 represents a methoxy group then W does not represent a hydroxy group.
The oxidation is preferably carried out in a mixture of dimethylsulphoxide and triethylamine at a temperature of 15"C to 30"C for a few minutes.
6-Methyl-8ss-formyl-ergoline and 6-methyl-8-oxo-ergoline are known compounds (Swiss Patent Specification No. 459243, Belgian Patent Specification No. 827930). The remaining compounds of the general formula I as above defined as novel and are included in the scope of the invention.
The ergoline derivatives prepared according to the invention are useful intermediates for the synthesis of new 8-substituted ergoline derivatives with good pharmacological activities.
The following Examples illustrate the invention.
Example 1 6-Methyl-8P-/2-oxoethyll-ergoline .
A suspension of 2.7 g of 6-methyl-8ss-(2- hydroxyethyl)-ergoline in 20 ml of dimethylsulphoxide and 20 ml of triethylamine was stirred at 25"C while 5 g of triethylamine:sulphur trioxide complex was added in small portions. The reaction mixture was stirred for 5 minutes and then poured into a solution of 30 ml of acetic acid and 300 ml of water. After 1/2 hours of continuous stirring, the solution was made basic with 5M aqueous sodium hydroxide solution. The resulting precipitate was filtered off, washed several times with water and crystallized from methanol affording 2.3 g of the title compound (m.p. 238-24-"C in 85% yield.
Example 2 6-Allyl-8P-formyl-ergoline Operating as in Example 1, but employing 6-allyl-8ss- hydroxymethyl-ergoline in place of 6-methyl-8p (2- -hydroxyethyl)-ergoline, the title compound (m.p. 132-134 C) was obtained in 45% yield.
Example 3 6-Ethyl-8p-formyl-ergoline Operating as in Example 1, but employing 6-ethyl-8ss- hydroxymethyl-ergoline in place of 6-methyl-8ss- (2- hydroxyethyl)-ergoline the title compound (m.p. 155-157 C) was obtained in 60% yield.
Example 4 6-Proypl-8ss-formyl-ergolíne Operating as in Example 1, but employing 6-propyl-8ss- hydroxymethyl-ergoline in place of 6-methyl 8p-(2- hydroxyethyl)-ergoline, the title compound (m.p. 147-149 C) was obtained in 50% yield.
Example 5 6-Methyl- 10-methoxy-8ss-form yl-ergoline Operating as in Example 1, but employing 6-methyl-10- methoxy-8ss-hydroxymethyl-ergoline in place of 6- methyl-8ss-2(2-hydroxethyl)-ergoline, the title compound (m.p. 129-131"C) was obtained in 45% yield.
Example 6 6-Methyl-8ss-formyl-ergoline Operating as in Example 1, but employing 6-methyi-8ss- hydroxymethyl-ergoline in place of 6-methyl 8p-(2- hydroxyethyl)-ergoline, the title compound (m.p. 169-172 C) was obtained in 60% yield.
Example 7 1,6-Dimethyl-8ss-formyl-ergoline Operating as in Example 1, but employing 1,6-dimethyl- 8P-hydroxymethyl-ergoiine in place of 6 methyl-8ss- (2-hydroxyethyl)-ergoline the title compound (m.p. 132-135 C) was obtained in 65% yield.
Example 8 6-methyl-8-oxo-ergoline Operating as in Example 1, but employing 6-methyl-8ss- hydroxy-ergoline in place of 6-methyl-8p-(2- hydroxyethyl)-ergoline, the title compound (m.p. 210-215"C) was obtained in 65% yield.
Example 9 6-methyl-8ss-(3-oxopropyl)-ergoline Operating as in Example 1, but employing 6-methyl-8ss- (3-hydroxypropyl)-ergoline in place of 6 methyl-8p- (2-hydroxyethyl)-ergoline, the title compound (m.p. 159-162"C) was obtained in 45% yield.

Claims (11)

1. A process for the preparation of an ergoline derivative having the general formula I as defined herein, the process comprising oxidizing an ergoline derivative having the general formula il as defined herein with a triethylamine:sulphur trioxide complex.
2. A process according to claim 1 which is carried out in a mixture of dimethylsulphoxide and triethylamine at a temperature of from 15"C to 30"C for a few minutes.
3. A process for the preparation of an ergoline derivative having the general formula I as herein defined, the process being substantially as described herein with reference to any of the Examples.
4. An ergoline derivative having the general formula I as herein defined, not being 6-methyl-8p-for- myl- ergoline and not being 6-methyl-8-oxo-ergoline.
5. 6-methyl-8p-(2-oxoethyl)-ergoline
6. 6-Allyl-8ss-formyl-ergoline.
7. 6-Ethyl-8p-formyl-ergoline.
8. 6-Propyl-8p-formyl-ergoline.
9. 6-Methyl-10-methoxy-8ss-formyl-ergoline.
10. 1,6-Dimethyl-8p-formyl-ergoline.
11. 6-Methyl-8ss-(3-oxopropyl)-ergoline.
GB08419150A 1984-07-27 1984-07-27 Ergoline derivatives Expired GB2162173B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08419150A GB2162173B (en) 1984-07-27 1984-07-27 Ergoline derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08419150A GB2162173B (en) 1984-07-27 1984-07-27 Ergoline derivatives

Publications (3)

Publication Number Publication Date
GB8419150D0 GB8419150D0 (en) 1984-08-30
GB2162173A true GB2162173A (en) 1986-01-29
GB2162173B GB2162173B (en) 1987-07-29

Family

ID=10564535

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08419150A Expired GB2162173B (en) 1984-07-27 1984-07-27 Ergoline derivatives

Country Status (1)

Country Link
GB (1) GB2162173B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2327277A (en) * 1997-06-16 1999-01-20 Trumpf Gmbh & Co Device for influencing a laser beam

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2327277A (en) * 1997-06-16 1999-01-20 Trumpf Gmbh & Co Device for influencing a laser beam

Also Published As

Publication number Publication date
GB8419150D0 (en) 1984-08-30
GB2162173B (en) 1987-07-29

Similar Documents

Publication Publication Date Title
Uhle The synthesis of 5-keto-1, 3, 4, 5-tetrahydrobenz [cd] indole. A synthesis of 4-substituted indoles
KR970003125B1 (en) METHOD FOR PRODUCING Ñß,ÑÔ-UNSATURATED KETOLACTONES
KR930009793B1 (en) Process for preparing benzopyran derivatives
KR970005315B1 (en) Process for the preparation of hethylene derivatives of androsta-1,4-diene-3,17-dione
US3926976A (en) 3,4-Dihydro-1,2,3-oxathiazine-4-ones and a process for their preparation
JP2731853B2 (en) Method for producing tri-lower alkanoyloxyboron
GB2039484A (en) Aminoalkyl and aminoalkoxy diphenylhydantoin derivatives and their preparation
US5498711A (en) Synthesis of 4,10-dinitro-2,6,8,12-tetraoxa-4,10-diazatetracyclo[5.5.0.05,903,11]dodecane
GB2162173A (en) Ergoline derivatives
US3960856A (en) Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide
KR100373997B1 (en) C.I.How to Make Reactive Blue 19
GB1564808A (en) 23,24-epoxy-25-hydroxycholestane derivatives
US2852531A (en) Tris-(2-tetrahydropyranyl) esters of 6, 8-bis (hydrocarbonmercapto)-4, 4-dicarboxy-5-ocaprylic acid and preparation thereof
EP0243646B1 (en) A process for the preparation of forskolin from 9-deoxy-forskolin and intermediates used therein
US4225524A (en) Steroid derivatives and process for preparing the same
US5118813A (en) Process for the preparation of compounds with antiulcer action
US4284562A (en) Process for preparing pyrrole-2-acetic acids
Chen et al. 6-thio and-seleno-β-D-glucose esters of dimethylarsinous acid
US4985563A (en) Process for the preparation of 6-piperidino-2,4-diamino pyrimidine-3-oxide
CA2287566A1 (en) 9,10-diazatricyclo¬4.2.1.12,5|decane and 9,10-diazatricyclo¬3.3.1.12,6|decane derivatives having analgesic activity
RO91516B (en) Process for preparing n-demethyl-morphinan derivatives
SU736872A3 (en) Method of preparing ergoline derivatives
US5274088A (en) Method for the preparation of (25r)-26-aminocholesterol
GB2108106A (en) Novel macrocyclic compounds and salts thereof useful for dissolving barium sulphate scale
US4394312A (en) Process for preparing rifamycin derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee